These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22527903)

  • 41. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).
    Tan S; Scherag A; Janssen OE; Hahn S; Lahner H; Dietz T; Scherag S; Grallert H; Vogel CI; Kimmig R; Illig T; Mann K; Hebebrand J; Hinney A
    BMC Med Genet; 2010 Jan; 11():12. PubMed ID: 20092643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study.
    Jaziri R; Lobbens S; Aubert R; Péan F; Lahmidi S; Vaxillaire M; Porchay I; Bellili N; Tichet J; Balkau B; Froguel P; Marre M; Fumeron F;
    Diabetes; 2006 Apr; 55(4):1157-62. PubMed ID: 16567542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.
    Song DK; Lee H; Hong YS; Sung YA
    BMC Endocr Disord; 2019 Dec; 19(1):145. PubMed ID: 31870342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic determinants of insulin action in polycystic ovary syndrome.
    Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].
    Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.
    Echiburú B; Pérez-Bravo F; Maliqueo M; Sánchez F; Crisosto N; Sir-Petermann T
    Metabolism; 2008 Dec; 57(12):1765-71. PubMed ID: 19013303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between PPAR-γ2 Pro12Ala genotype and insulin resistance is modified by circulating lipids in Mexican children.
    Stryjecki C; Peralta-Romero J; Alyass A; Karam-Araujo R; Suarez F; Gomez-Zamudio J; Burguete-Garcia A; Cruz M; Meyre D
    Sci Rep; 2016 Apr; 6():24472. PubMed ID: 27075119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
    Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
    Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.
    Tönjes A; Scholz M; Loeffler M; Stumvoll M
    Diabetes Care; 2006 Nov; 29(11):2489-97. PubMed ID: 17065690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
    Jones MR; Mathur R; Cui J; Guo X; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5034-8. PubMed ID: 19837928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High BMI and Insulin Resistance Are Risk Factors for Spontaneous Abortion in Patients With Polycystic Ovary Syndrome Undergoing Assisted Reproductive Treatment: A Systematic Review and Meta-Analysis.
    Sun YF; Zhang J; Xu YM; Cao ZY; Wang YZ; Hao GM; Gao BL
    Front Endocrinol (Lausanne); 2020; 11():592495. PubMed ID: 33343510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.
    Zhang H; Zhu S; Chen J; Tang Y; Hu H; Mohan V; Venkatesan R; Wang J; Chen H
    Diabetes Care; 2012 Jun; 35(6):1388-93. PubMed ID: 22619290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis.
    Xie R; Tang S; Yang Y
    J Diabetes Complications; 2022 Oct; 36(10):108261. PubMed ID: 36055011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-Nucleotide Polymorphism on Exon 17 of Insulin Receptor Gene Influences Insulin Resistance in PCOS: A Pilot Study on North Indian Women.
    Gangopadhyay S; Agrawal N; Batra A; Kabi BC; Gupta A
    Biochem Genet; 2016 Apr; 54(2):158-68. PubMed ID: 26721804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome.
    Yilmaz M; Yurtçu E; Demirci H; Ergün MA; Ersoy R; Karakoç A; Yetkin I; Cakir N; Ayvaz G; Arslan M
    J Endocrinol Invest; 2009 Jan; 32(1):13-7. PubMed ID: 19337008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic polymorphisms of melatonin receptors 1A and 1B may result in disordered lipid metabolism in obese patients with polycystic ovary syndrome.
    Xu XH; Kou LC; Wang HM; Bo CM; Song XC
    Mol Med Rep; 2019 Mar; 19(3):2220-2230. PubMed ID: 30664204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Shabani A; Foroozanfard F; Kavossian E; Aghadavod E; Ostadmohammadi V; Reiter RJ; Eftekhar T; Asemi Z
    J Affect Disord; 2019 May; 250():51-56. PubMed ID: 30831541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.